EV Biologics

With a focus on advancements in medical diagnostics and therapeutics through EV research and development, EV Biologics is building a world-class team of molecular biologists, analytical biochemists, nanoparticle biophysicists, synthetic organic chemists biomedical engineers, software and systems engineers, as well as physicians and surgeons specializing in regenerative medical technology. Each member of our team brings expertise in science, medicine, blockchain, AI and business that will enable EV Biologics to rapidly develop innovative medical technology for the diagnosis and treatment of disease and injury. EV Biologics is dedicated to the advancement of the science and technology of extracellular vesicles for development of the next generation of diagnostics, therapeutics and regenerative products. Exosome research with a focus on clinical applications has and will continue to enable the optimization of therapeutic agents for specific clinical indications. Designing biocompatible carriers and delivery systems will also augment the stability and efficacy of engineered exosomes. Development of simple, safe, effective regenerative products using these combined EV technologies will revolutionize medicine, providing non-invasive solutions to difficult clinical problems.